Cannabis
Is CBG the Next CBD? Exploring the science of the new “it” cannabinoid
The legal cannabis market that emerged following the 2018 Farm Bill has led to the marketing of several lesser-known cannabinoids—compounds found almost exclusively in cannabis. It has also led to a lot of confusion because of several reasons: there are hundreds of these compounds, they all seem to have distinct properties, and relatively little clinical […]
GLP-1 Agonists in Psychiatry: A new perspective
Obesity and type 2 diabetes mellitus (T2DM) are two of the most pressing dangers to public health facing the United States today. This should come as no surprise, as these interrelated conditions have been affecting an ever-growing number of Americans for several decades. One piece of good news has been the development of medicines such […]
Cannabis, ADHD, and Quality of Life
As seen in Psychology Today. Attention-deficit/hyperactivity disorder (ADHD) has become one of the most commonly diagnosed psychiatric disorders in recent years, with an estimated global prevalence of 2.5% in adults and 5% in children. In the United States, prevalence among individuals between the ages of 4 and 17 years was estimated to be 10% as […]